Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $55.6400 (1.15%) ($55.6400 - $55.6400) on Tue. Jan. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.24% (three month average) | RSI | 48 | Latest Price | $55.6400(1.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.2% a day on average for past five trading days. | Weekly Trend | HALO declines -2.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(36%) XBI(36%) IFRA(33%) IWO(31%) VFMO(31%) | Factors Impacting HALO price | HALO will decline at least -1.12% in a week (0% probabilities). VXX(-15%) VIXM(-11%) UUP(-11%) IGOV(-11%) EDOC(-11%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.12% (StdDev 2.24%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $50.96(-8.41%) | Resistance Level | $56.58 | 5 Day Moving Average | $54.85(1.44%) | 10 Day Moving Average | $55.69(-0.09%) | 20 Day Moving Average | $56.58(-1.66%) | To recent high | -6.2% | To recent low | 34.5% | Market Cap | $7.604b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |